CarboHyde offers Sulfobutylether-beta-cyclodextrin sodium salt of USP or EP grade, supported by more than a decade of manufacturing expertise and a consistently updated DMF filed with the FDA.
Specification of pharma-grade Sulfobutylether-beta-cyclodextrin sodium salt
Sulfobutyl-beta-cyclodextrin (SBECD) is a versatile, high-performance excipient widely used in the pharmaceutical industry. Its unique chemical structure and properties make it essential in various applications, including solubility enhancement, stabilization, and advanced drug delivery systems.
Key Benefits:
- Improved Solubility:
SBECD significantly enhances the solubility of poorly water-soluble drugs, increasing their bioavailability and therapeutic effectiveness. - Enhanced Stability:
By forming inclusion complexes with active pharmaceutical ingredients (APIs), SBECD improves chemical and physical stability, protecting sensitive molecules from degradation. - Controlled Drug Release:
Its ability to modulate drug release rates enables precise and sustained delivery, enhancing patient compliance and treatment outcomes. - Reduced Toxicity and Irritation:
SBECD can reduce the toxicity and irritation of certain APIs, ensuring safer formulations and improved patient tolerability. - Versatile Applications:
Suitable for oral, injectable, ophthalmic, and nasal drug delivery systems, SBECD is a reliable choice across a wide range of formulation types. - Regulatory Compliance:
SBECD is included in pharmacopeias and has established regulatory acceptance, ensuring ease of use in product development.
Why Choose SBECD?
With its unparalleled ability to enhance the performance of pharmaceutical formulations, SBECD is the excipient of choice for researchers and manufacturers striving to deliver innovative and effective therapies.
If you would like a quote or further information, please complete this form or send an email to sales@carbohyde.com.